DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma
- Status
- UNKNOWN
- Phase
- PHASE2
Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Biochemotherapy With Temozolomide for Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
- Status
- UNKNOWN
- Phase
- PHASE2
Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE3
Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
- Status
- TERMINATED
- Phase
- N/A
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
a Phase II Study in Primary Central Nervous System Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE1
O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed)
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE2